Jump to content
RemedySpot.com

Research and Markets HCV R&D and Business Development Database - Over 150 Compa

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 04

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Research and Markets: HCV R & D and Business Development Database - Over 150

Companies From 18 Different Countries

Thursday July 29, 12:27 pm ET

DUBLIN--(BUSINESS WIRE)--July 29, 2004--Research and Markets

(http://www.researchandmarkets.com) has announced the addition of HCV R & D and

Business Development Database to their offering.

This unique CD-ROM database product is one of the most comprehensive and up to

date information sources on chronic hepatitis C virus R & D and business

development. The database contains extensive corporate, R & D, and business

collaboration information. The company profile database covers over 150

companies from 18 different countries. The R & D database covers over 160 pipeline

drugs from early stage as target validation to late stage as phase III. All

projects have as far as possible been assigned with specified targets, such as

IMPDH, RdRp, P7 etc, and mechanism, such as anti-fibrotic, antisense, immune

modulator etc. In the collaboration database more than 80 unique business

collaborations have been described.

http://biz./bw/040729/295593_1.html

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Research and Markets: HCV R & D and Business Development Database - Over 150

Companies From 18 Different Countries

Thursday July 29, 12:27 pm ET

DUBLIN--(BUSINESS WIRE)--July 29, 2004--Research and Markets

(http://www.researchandmarkets.com) has announced the addition of HCV R & D and

Business Development Database to their offering.

This unique CD-ROM database product is one of the most comprehensive and up to

date information sources on chronic hepatitis C virus R & D and business

development. The database contains extensive corporate, R & D, and business

collaboration information. The company profile database covers over 150

companies from 18 different countries. The R & D database covers over 160 pipeline

drugs from early stage as target validation to late stage as phase III. All

projects have as far as possible been assigned with specified targets, such as

IMPDH, RdRp, P7 etc, and mechanism, such as anti-fibrotic, antisense, immune

modulator etc. In the collaboration database more than 80 unique business

collaborations have been described.

http://biz./bw/040729/295593_1.html

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Research and Markets: HCV R & D and Business Development Database - Over 150

Companies From 18 Different Countries

Thursday July 29, 12:27 pm ET

DUBLIN--(BUSINESS WIRE)--July 29, 2004--Research and Markets

(http://www.researchandmarkets.com) has announced the addition of HCV R & D and

Business Development Database to their offering.

This unique CD-ROM database product is one of the most comprehensive and up to

date information sources on chronic hepatitis C virus R & D and business

development. The database contains extensive corporate, R & D, and business

collaboration information. The company profile database covers over 150

companies from 18 different countries. The R & D database covers over 160 pipeline

drugs from early stage as target validation to late stage as phase III. All

projects have as far as possible been assigned with specified targets, such as

IMPDH, RdRp, P7 etc, and mechanism, such as anti-fibrotic, antisense, immune

modulator etc. In the collaboration database more than 80 unique business

collaborations have been described.

http://biz./bw/040729/295593_1.html

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Research and Markets: HCV R & D and Business Development Database - Over 150

Companies From 18 Different Countries

Thursday July 29, 12:27 pm ET

DUBLIN--(BUSINESS WIRE)--July 29, 2004--Research and Markets

(http://www.researchandmarkets.com) has announced the addition of HCV R & D and

Business Development Database to their offering.

This unique CD-ROM database product is one of the most comprehensive and up to

date information sources on chronic hepatitis C virus R & D and business

development. The database contains extensive corporate, R & D, and business

collaboration information. The company profile database covers over 150

companies from 18 different countries. The R & D database covers over 160 pipeline

drugs from early stage as target validation to late stage as phase III. All

projects have as far as possible been assigned with specified targets, such as

IMPDH, RdRp, P7 etc, and mechanism, such as anti-fibrotic, antisense, immune

modulator etc. In the collaboration database more than 80 unique business

collaborations have been described.

http://biz./bw/040729/295593_1.html

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...